One Case of a BRCA1 Germ Line Mutation Ovarian Carcinoma Patient Based on Abnormal Immunohistochemistry Finding

참고문헌 (10)

1. Lynch HT, "Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management", Mol Oncol, 3, pp.97~137 (2009)
2. Miki Y, "A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1", Science, 266, pp.66~71 (1994)
3. Wooster R, "Identification of the breast cancer susceptibility gene BRCA2", Nature, 378, pp.789~792 (1995)
4. 강윤경, "Microsatellite Instability and Mismatch Repair Protein (hMLH1, hMSH2) Expression in Intrahepatic Cholangiocarcinoma", Journal of Pathology and Translational Medicine, 39(1), pp.9~14 (2005), 대한병리학회
5. Antoniou A, "Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies", Am J Hum Genet, 72, pp.1117~1130 (2003)
6. Kauff ND, "Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation", N Engl J Med, 346, pp.1609~1615 (2002)
7. Whittemore AS, "Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer", Am J Hum Genet, 60, pp.496~504 (1997)
8. Kim H, "Characteristics and spectrum of BRCA1 and BRCA2 mutations in 3,922 Korean patients with breast and ovarian cancer", BREAST CANCER RESEARCH AND TREATMENT, 134(3), pp.1315~1326 (2012), SPRINGER
9. 황태숙, "Molecular Biologic Techniques in Cytopathologic Diagnosis", Journal of Pathology and Translational Medicine, 43(5), pp.387~392 (2009), 대한병리학회
10. Eisen A, "Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study", J Clin Oncol, 23, pp.7491~7496 (2005)

관련 논문AI추천